Diagnostic mycology: Controversies and consensus - what should laboratories do? Part II

Clinical Microbiology Newsletter

Volumn 28, Issue 17, 2006, Pages 129-134

  Nye, Melinda B ^a   Beard, Melodie A ^a   Body, Barbara A ^a  

^a LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; NUCLEIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; DNA SEQUENCE; FUNGUS; FUNGUS IDENTIFICATION; LABORATORY DIAGNOSIS; MOULD; MYCOLOGY; MYCOSIS; NONHUMAN; NUCLEIC ACID ANALYSIS; YEAST;

EID: 33747363772     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2006.08.003     Document Type: Article

References (57)

1. De Hoog G.S., et al. Atlas of clinical fungi. 2nd ed. (2001), American Society for Microbiology, Washington, D.C.
2. Larone D.H. Medically important fungi: a guide to identification. 4th ed. (2002), American Society for Microbiology, Washington, D.C.
3. St-Germain G., and Summerbell R. Identifying filamentous fungi: a clinical laboratory handbook (1995), Star Publishing Company, Belmont, CA
4. In: Murray P.R., et al. (Ed). Manual of clinical microbiology. 8th ed. (2003), American Society for Microbiology, Washington, D.C.
5. Wang C.J.K., and Zabel R.A. Identification manual for fungi from utility poles in the eastern United States (1990), American Type Culture Collection, Rockville, MD
6. Cook V.J., et al. Conventional methods versus 16S ribosomal DNA sequencing for identification of nontuberculous mycobacteria: cost analysis. J. Clin. Microbiol. 41 (2003) 1010-1015
7. Hall L., Wohlfiel S., and Roberts G.D. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J. Clin. Microbiol. 42 (2004) 622-626
8. Turenne C.Y., et al. Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system. J. Clin. Microbiol. 37 (1999) 1846-1851
9. Henry T., Iwen P.C., and Hinrichs S.H. Identification of Aspergillus species using internal transcribed spacer regions 1 and 2. J. Clin. Microbiol. 38 (2000) 1510-1515
10. Chen Y.-C., et al. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J. Clin. Microbiol. 39 (2001) 4042-4051
11. Pryce T.M., et al. Rapid identification of fungi by sequencing the ITS1 and ITS2 regions using an automated capillary electrophoresis system. Med. Mycol. 41 (2003) 369-381
12. Rakeman J.L., et al. Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J. Clin. Microbiol. 43 (2005) 3324-3333
13. Ciardo D.E., et al. Mould identification in the clinical laboratory by sequencing of the ITS region: construction and evaluation of a specialised database, abstr. C-218. Abstr. 105th Gen. Meet. Am. Soc. Microbiol. (2005), American Society for Microbiology, Washington, D.C. 118
14. Hall L., Wohlfiel S., and Roberts G.D. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. J. Clin. Microbiol. 41 (2003) 5099-5102
15. Ninet B., et al. Identification of dermatophyte species by 28S ribosomal DNA sequencing with a commercial kit. J. Clin. Microbiol. 41 (2003) 826-830
16. National Committee for Clinical Laboratory Standards. Reference method for broth dilution testing of yeasts. approved standard M27-A2. 2nd ed. (2002), National Committee for Clinical Laboratory Standards, Wayne, PA
17. National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts, approved guideline M44-A (2004), National Committee for Clinical Laboratory Standards, Wayne, PA
18. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard M38-A (2002), National Committee for Clinical Laboratory Standards, Wayne, PA
19. Lombardi G., et al. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts. Mycoses 47 (2004) 397-401
20. Pfaller M.A., Espinel-Ingroff A., and Jones R.N. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. J. Clin. Microbiol. 42 (2004) 4577-4780
21. Matar M.J., et al. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob. Agents Chemother. 47 (2003) 1647-1651
22. Pfaller M.A., Messer S.A., and Bolmstrom A. Evaluation of E-test for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn. Microbiol. Infect. Dis. 32 (1998) 223-227
23. Espinel-Ingroff A., and Rezusta A. E-test method for testing susceptibilities of Aspergillus spp. to the new trizoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J. Clin. Microbiol. 40 (2002) 2101-2107
24. Pfaller J.B., et al. In vitro susceptibility testing of Aspergillus spp: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J. Clin. Microbiol. 41 (2003) 1126-1129
25. Serrano M.C., et al. A comparative study of the disc diffusion method with broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp. J. Antimicrob. Chemother. 53 (2004) 739-742
26. Martín-Mazuelos E., et al. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J. Antimicrob. Chemother. 52 (2003) 365-370
27. Fernandez-Torres B., et al. Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes. Med. Mycol. 41 (2003) 125-130
28. Chaturvedi V., Ramani R., and Pfaller M.A. Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans. J. Clin. Microbiol. 42 (2004) 2249-2251
29. Mitchell M., Hudspeth M., and Wright A. Flow cytometry sus-ceptibility testing for the antifungal caspofungin. J. Clin. Microbiol. 43 (2005) 2586-2589
30. Peter J., et al. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp. J. Clin. Microbiol. 43 (2005) 3788-3792
31. Pina-Vaz C., et al. Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry. J. Clin. Microbiol. 43 (2005) 4674-4679
32. Maertens J.J., et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J. Clin. Microbiol. 37 (1999) 3223-3228
33. Sulahian A., et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91 (2001) 311-318
34. Verweij P.E., et al. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J. Clin. Microbiol. 33 (1995) 1912-1914
35. Husain S., et al. Prospective assessment of Platelia™ Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am. J. Transplant 4 (2004) 796-802
36. Fortun J., et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 71 (2001) 145-149
37. Maertens J.J., et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br. J. Haematol 126 (2004) 852-860
38. Bretagne S., et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J. Infect. 35 (1997) 7-15
39. Adam O., et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin. Infect. Dis. 38 (2004) 917-920
40. Viscoli C., et al. False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin. Infect. Dis. 38 (2004) 913-916
41. Mattei D., et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J. Clin. Microbiol. 42 (2004) 5362-5363
42. Dalle F., et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J. Clin. Microbiol. 43 (2005) 2929-2931
43. El Saleeby C.M., et al. Discordant rise in galactomannan antigenemia in a patient with resolving aspergillosis, renal failure, and ongoing hemodialysis. J. Clin. Microbiol. 43 (2005) 3560-3563
44. Marr K.A., et al. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40 (2005) 1762-1769
45. Pazos C., Pontón J., and Del Palacio A. Contribution of (1→3)β-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening galactomannan. J. Clin. Microbiol. 43 (2005) 299-305
46. Kato A., et al. Elevation of blood (1→3)β-d-glucan concentrations in hemodialysis patients. Nephron J. 89 (2001) 15-19
47. Digby J., et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin. Diagn. Lab. Immunol. 10 (2003) 882-885
48. Weiner M.H., and Yount W.J. Mannan antigenemia in the diagnosis of invasive Candida infection. J. Clin. Investig. 58 (1976) 1045-1054
49. Sendid B., et al. Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diag-nosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 51 (2002) 433-442
50. Sendid B., et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J. Clin. Microbiol. 41 (2003) 4551-4558
51. Rimek D., Singh J., and Kappe R. Cross-reactivity of the PLATELIA Candida antigen detection enzyme immunoassay with fungal antigen extracts. J. Clin. Microbiol. 41 (2003) 3395-3398
52. Loeffler J., et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the Light Cycler system. J. Clin. Microbiol. 38 (2000) 586-590
53. Pham A.S., et al. Diagnosis of invasive mold infection by real-time quantitative PCR. Am. J. Clin. Pathol. 119 (2003) 38-44
54. Challier S., et al. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 42 (2004) 844-846
55. Rantakokko-Jalava K., et al. Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis. J. Clin. Microbiol. 41 (2003) 4304-4311
56. Musher B., et al. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42 (2004) 5517-5522
57. White P.L., Archer A.E., and Barnes R.A. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J. Clin. Microbiol. 43 (2005) 2181-2187